TipRanks
Go Ultimate55% OFF

Paul Rubin Insider Profile

4 Followers

Paul Rubin, CMO at BioAge Labs, Inc., holds 0.00 shares in BioAge Labs, Inc. (Ticker: BIOA), holds 340.02K shares in XOMA Royalty Corporation (Ticker: XOMA), holds ― shares in Viridian Therapeutics (Ticker: VRDN).

Paul Rubin's Trading History

BIOA
BioAge Labs, Inc.
Apr 03, 2026CMOUninformative Buy44.57K$0.00
XOMA
XOMA Royalty Corporation
Mar 22, 2016―Uninformative Sell9.40K$13.66M
~CRTX
Cornerstone Therapeutics Inc
――――
VRDN
Viridian Therapeutics
―EVP, Research & Development――

You May Also Like

Paul Rubin insider profile FAQ

What stocks does Paul Rubin hold?
Paul Rubin holds: BIOA, XOMA, VRDN, ~CRTX stocks.
What was Paul Rubin’s latest transaction?
Paul Rubin’s latest transaction was an Uninformative Buy of $44.57K.
What is Paul Rubin's role in BioAge Labs, Inc.?
Paul Rubin's role in BioAge Labs, Inc. is CMO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.